News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Therapeuticsmd Inc
(NQ:
TXMD
)
1.770
+0.020 (+1.14%)
Streaming Delayed Price
Updated: 3:27 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Therapeuticsmd Inc
< Previous
1
2
Next >
TherapeuticsMD Announces Second Quarter 2024 Financial Results
August 12, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces First Quarter 2024 Financial Results
May 10, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
March 29, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Third Quarter 2023 Financial Results
November 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Second Quarter 2023 Financial Results
August 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces First Quarter 2023 Financial Results
May 15, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
April 07, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
January 03, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
December 04, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Third Quarter 2022 Financial Results
November 14, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Additional $7 Million Private Placement
October 31, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces $7 Million Private Placement
October 03, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
September 12, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Second Quarter 2022 Financial Results
August 15, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022
August 08, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
August 01, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Expiration of Tender Offer
July 13, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD
May 31, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
TXMD Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of TherapeuticsMD, Inc. Is Fair to Shareholders
May 31, 2022
From
Halper Sadeh LLP
Via
Business Wire
TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD
May 31, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®
May 20, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces First Quarter 2022 Financial Results
May 16, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022
May 10, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million
April 14, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®
December 10, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) — Allowing for a May 25, 2032 Generic Entry Date
December 08, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Third Quarter 2021 Financial Results
November 11, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
November 11, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021
October 27, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer
October 15, 2021
From
TherapeuticsMD, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.